Can Leukemia Be Transmitted From Person to Person?

Leukemia cannot be passed from one person to another through physical contact, sharing food, breathing the same air, or any form of everyday interaction. It is not contagious the way a cold or the flu is. Your immune system is extraordinarily effective at recognizing and destroying foreign cells, which means that even if cancer cells from someone else entered your body, they would almost certainly be eliminated before they could take hold. There are, however, a few highly specific biological scenarios where something resembling transmission has occurred, and at least one virus that can be spread between people and, in a small fraction of those infected, eventually trigger a type of leukemia decades later.

Why Your Immune System Makes Transmission Nearly Impossible

The core reason leukemia is not transmissible comes down to how aggressively your body rejects foreign tissue. Every human cell carries a set of surface proteins that function like a biological fingerprint, unique to each individual. When your immune system encounters cells that carry a different set of these markers, it mounts a rapid and powerful attack. This is the same process that makes organ transplants so difficult without immunosuppressive drugs and why bone marrow donors must be carefully matched to recipients.

Research into stem-cell transplantation has demonstrated just how sensitive this recognition system is. Even among donors and patients matched at ten key immune markers, mismatches at a single additional marker can trigger a strong immune response. Studies of donor T cells show they readily expand into populations capable of killing cells carrying even one unfamiliar surface protein, which occurs in the vast majority of donor-patient pairs.¹ In other words, leukemia cells from another person’s body carry foreign markers that would immediately mark them for destruction. Casual contact, a shared glass, a kiss, or even exposure to someone’s blood would not give leukemia cells any realistic chance of survival inside your body.

HTLV-1 and the Virus That Can Eventually Cause Leukemia

There is one important exception to the “leukemia is not transmissible” rule, but it requires a careful distinction. The virus itself spreads between people; the leukemia does not. Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first cancer-causing retrovirus discovered in humans. It spreads through sexual contact, from mother to child during breastfeeding, and through blood transfusion.² In regions where HTLV-1 is common, particularly parts of Japan, the Caribbean, Central Africa, and South America, the virus circulates in ways similar to other blood-borne infections.

The critical nuance is what happens after infection. The overwhelming majority of people infected with HTLV-1 never develop leukemia. Only a small percentage, generally estimated between two and six percent over a lifetime, go on to develop adult T-cell leukemia/lymphoma (ATLL). For those who do, the time between infection and disease onset is typically measured in decades. So while HTLV-1 is unquestionably transmissible and unquestionably linked to leukemia, calling ATLL a “transmitted leukemia” would be misleading. What spreads is the virus. The leukemia itself develops independently inside the infected person’s own cells, often 20 to 40 years later, driven by a complex chain of genetic damage that the virus sets in motion but that most carriers’ immune systems manage to keep in check indefinitely.

Blood banks in many countries now screen donations for HTLV-1, which has substantially reduced one route of spread. Where screening is not routine, transfusion remains a risk for acquiring the virus, though again, acquiring the virus and developing leukemia are very different things.

Viruses and Blood Cancers More Broadly

HTLV-1 is not the only virus linked to a blood cancer. Epstein-Barr virus (EBV), best known as the cause of infectious mononucleosis (mono), has a well-established connection to certain lymphomas. A large study following people after a bout of mono found that the risk of EBV-positive Hodgkin’s lymphoma was roughly four times higher than in the general population, with a median time from mono to lymphoma diagnosis of about four years.³ Hodgkin’s lymphoma is not leukemia, but the two are closely related blood cancers, and the pattern is similar: a transmissible virus raises the risk of a cancer that is itself not transmissible.

The same logic applies to hepatitis C and certain lymphomas, HIV and Kaposi sarcoma, and several other virus-cancer pairs. In every case, the infection can spread from person to person, but the cancer that sometimes develops later cannot. This distinction matters because it means preventing the infection (through vaccination where available, safe sex practices, clean needles, screened blood supplies) effectively prevents the associated cancer. It does not mean that being near someone who has that cancer puts you at any risk.

Twins Sharing Leukemia Before Birth

One genuinely startling scenario involves identical twins where one child develops leukemia in early childhood. Researchers have found that when this happens, the other twin sometimes develops the same leukemia, and genetic analysis shows the cancer cells in both children trace back to a single original mutation. The mechanism is not person-to-person transmission in the way we normally think about it, but rather something unique to identical twins who share a placenta.

During pregnancy, identical twins who share a placenta also share blood vessel connections. Pre-leukemic cells that arise in one twin can cross into the other twin’s bloodstream through these connections. Using sensitive genetic assays, researchers have detected persistent pre-leukemic fusion gene sequences in the blood of healthy co-twins years after birth, demonstrating that these clones can cross from one twin to another and remain dormant without necessarily progressing to full-blown leukemia.⁴

This is as close to “natural transmission” of leukemia as exists in humans, and it requires conditions that are obviously impossible to replicate in everyday life: two genetically identical individuals sharing a blood supply in a confined space for months. The shared immune profile of identical twins means the pre-leukemic cells are not recognized as foreign, so they are not destroyed the way they would be in any genetically distinct person. Even within this unusual scenario, the dormant clones do not always become leukemia in the second twin. Additional mutations must accumulate independently before the disease develops.

Donor-Derived Leukemia Through Organ Transplants

Another rare situation in which leukemia has effectively traveled from one person to another involves organ transplantation. In a documented case, acute myeloid leukemia that was undetected in a deceased organ donor was transmitted to two kidney recipients and one liver recipient.⁵ The key factors are specific to the transplant setting: the recipients were receiving immunosuppressive drugs to prevent organ rejection, which simultaneously suppressed the immune response that would normally destroy foreign cancer cells. The leukemia cells, riding along in the transplanted organs, were given an artificial safe harbor.

These cases are extraordinarily rare and are tracked closely by transplant organizations worldwide. Donors are screened for active malignancies, but some cancers are undetectable at the time of donation. When donor-derived cancers do appear in recipients, the first-line treatment is often to reduce or stop immunosuppression, which can allow the recipient’s immune system to reject the foreign cancer cells on its own. The fact that this approach sometimes works underscores just how powerful the immune barrier is: even after a cancer has established itself in a new host, simply restoring normal immune surveillance may be enough to eliminate it.

Does Living Near Someone With Leukemia Raise Your Risk?

The idea that leukemia might cluster geographically or spread through communities has been investigated multiple times, particularly for childhood leukemia. One hypothesis, sometimes called the “population mixing” hypothesis, suggested that large influxes of people into previously isolated communities might expose children to new infections that could trigger leukemia. If true, you might expect to see clusters of cases in certain towns or neighborhoods.

A nationwide study in Finland examined this possibility using multiple analytical methods and found no clear evidence that childhood leukemia clusters geographically or correlates with population mixing patterns.⁶ While individual studies in other countries have occasionally reported what look like clusters, these have generally not held up to rigorous statistical analysis, and none have suggested direct person-to-person spread. The scientific consensus is that living with, working alongside, or caring for someone with leukemia does not raise your risk of developing it.

Transmissible Cancers in Animals

If leukemia cannot spread between humans, can it spread between other species? The answer is yes, and the examples are fascinating precisely because they highlight what would have to go wrong for something similar to happen in people.

The most dramatic case involves soft-shell clams along the Atlantic coast of North America. Researchers discovered that a form of leukemia in these clams is caused not by a virus but by cancer cells that spread directly from one clam to another through seawater. Genetic analysis showed the cancer cells were clonal, meaning they all traced back to a single original clam, and they had been spreading as a living cell line through marine populations.⁷ This transmissible neoplasia has since been found spreading from Atlantic populations into Pacific waters, detected recently in Puget Sound in hybridizing clam populations.⁸

Blue mussels have their own version. Two lineages of transmissible cancer, both originating from a single mussel species, have been found spreading through mussel populations worldwide. One lineage has crossed from the Northwest Pacific into populations in other oceans, demonstrating that these cancer cell lines can travel enormous distances and persist for long periods.⁹

Among mammals, the longest-studied transmissible cancer is canine transmissible venereal tumor (CTVT), which has persisted as a clonal cell line passed between dogs for thousands of years. CTVT survives by actively suppressing the host dog’s local immune response, secreting molecules that dampen immune activity and downregulating the surface markers that would normally flag it as foreign tissue.¹⁰ Even so, most dogs’ immune systems eventually overcome the tumor and clear it without treatment.

Feline leukemia virus (FeLV) offers yet another angle. In experimental settings, cats carrying the virus transmitted FeLV to cage-mates through close contact, with uninfected control cats developing evidence of infection weeks after exposure to viremic cage-mates.¹¹ Like HTLV-1 in humans, FeLV is a transmissible virus that can cause leukemia, not a transmissible leukemia itself. The distinction is the same one that applies to the human situation, just in a different species.

Why Transmissible Cancer Works in Clams but Not in People

The bivalve examples are striking because they represent actual cancer cells, not viruses, jumping between individuals. Several features of clam and mussel biology make this possible. Marine bivalves filter enormous volumes of water, constantly exposing their tissues to whatever cells are floating in the environment. Their immune systems are far simpler than those of mammals, lacking the sophisticated cell-surface recognition that allows your body to distinguish self from non-self at a molecular level. And within a species, the genetic diversity may be low enough that foreign cancer cells are not flagged as dramatically different.

Humans share none of these vulnerabilities. Our adaptive immune system, with its vast repertoire of T cells and antibodies, is precisely engineered to detect and destroy cells that do not belong. The transplant cases described earlier illustrate this by exception: transmission succeeded only when immunosuppressive drugs knocked out the very defenses that normally make it impossible. The twin scenario succeeded because the two individuals were genetically identical. In every case where leukemia has appeared to “transfer” between humans, the normal immune barriers were either absent or artificially disabled.

Living With or Caring for Someone Who Has Leukemia

If you have a family member, partner, or friend undergoing treatment for leukemia, there is no medical reason to limit physical contact, shared meals, or time spent together on the basis of transmission risk. You cannot catch leukemia from hugging, kissing, sharing utensils, or living in the same household. Blood and body fluid precautions during treatment are about protecting the patient, whose immune system is often severely weakened by chemotherapy, not about protecting the people around them.

The confusion often arises from the language surrounding HTLV-1 and other oncogenic viruses. When news articles mention a “leukemia virus” or “virus-caused leukemia,” people understandably wonder whether the leukemia itself is infectious. The answer is that the virus, where one is involved, may be transmissible through specific routes, but the leukemia that develops in a minority of infected people years or decades later is a disease of that individual’s own cells. It arises internally and stays internal. No quarantine, no special precautions for household contacts, and no risk from ordinary human closeness.

For those worried about HTLV-1 specifically, testing is available, and the same safer-sex and blood-safety practices that reduce risk for other blood-borne infections apply. Screening of blood donations has made transfusion-related infection rare in countries where it is standard practice. And because the lifetime risk of developing ATLL even among those who carry HTLV-1 remains low, infection is not a leukemia sentence. It is a risk factor, like many others, that can be monitored over time.